| 04:50a | Berenberg leaves Siemens Healthineers at 'Buy' - Target 58 euros | DP |
| 04:18a | SIEMENS HEALTHINEERS : Berenberg gives a Buy rating | MD |
| 06/01 | Insider Sell: Danaher Corp | MT |
| 05/31 | Morgan Stanley Adjusts Price Target on Intuitive Surgical to $310 From $285, Keeps Equa.. | MT |
| 05/31 | Bernstein Adjusts Intuitive Surgical Price Target to $365 From $350, Maintains Outperfo.. | MT |
| 05/31 | Boston Scientific Seeks Tuck-In M&A | CI |
| 05/31 | Transcript : Boston Scientific Corporation Presents at Bernstein’s 39th .. | CI |
| 05/26 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| 05/26 | Sector Update: Health Care | MT |
| 05/26 | Titan Medical Signs IP Licensing Agreement With Intuitive Surgical | DJ |
| 05/26 | Titan Medical Signs License Agreement with Intuitive Surgical | CI |
| 05/26 | Titan Medical Says Signed License Agreement with Nasdaq's Intuitive Surgical | MT |
| 05/26 | Refile-- Titan Medical Brief: Says Signed License Agreement.. | MT |
| 05/26 | Titan Medical Brief: Says Signe License Agreement with Intuitive Sur.. | MT |
| 05/25 | Boston Scientific's Scrapping of Deal for Majority Stake in M.I. Tech Welcomed by US Fe.. | MT |
| 05/25 | Boston Scientific's Scrapping of Deal for Majority Stake in M.I. Tech Welcomed by US Fe.. | MT |
| 05/24 | Sector Update: Health Care Stocks Decline | MT |
| 05/24 | Sector Update: Health Care Stocks Lower on Wednesday Afternoon | MT |
| 05/24 | Sector Update: Health Care | MT |
| 05/24 | Illumina Strong Enough to Withstand Loss of Chair, CEO Amid Proxy Battle, Board Member .. | MT |
| 05/24 | UBS raises target for Siemens Healthineers to 61 euros - 'Buy' | DP |
| 05/24 | SIEMENS HEALTHINEERS : UBS reiterates its Buy rating | MD |
| 05/21 | Medical technology industry with concern and a bit of optimism | DP |
| 05/19 | SIEMENS HEALTHINEERS : Gets a Buy rating from Bernstein | MD |
| 05/19 | SIEMENS HEALTHINEERS : Receives a Buy rating from Berenberg | MD |
| 05/18 | Truist Securities Adjusts Price Target on Intuitive Surgical to $347 From $325, Maintai.. | MT |
| 05/17 | Insider Sell: Boston Scientific | MT |
| 05/17 | Multinational Medical Device Companies Increase Local Production in China | MT |
| 05/17 | Raised outlook catapults Siemens toward record high | DP |
| 05/17 | Siemens raises forecasts again - driven by digitization | DP |
| 05/17 | SIEMENS HEALTHINEERS : DZ Bank sticks Neutral | MD |
| 05/17 | Siemens generates more profit thanks to digitization | DP |
| 05/16 | Vaccine reagent vendor Maravai draws private equity interest-sources | RE |
| 05/16 | Intuitive Surgical Names David Rosa President | DJ |
| 05/16 | Intuitive Surgical, Inc. Announces Executive Changes | CI |
| 05/16 | Boston Scientific Corporation (NYSE:BSX) cancelled t.. | CI |
| 05/15 | Standard BioTools Names Jeffrey Black CFO; Shares Rise | MT |
| 05/12 | SIEMENS HEALTHINEERS : Buy rating from Deutsche Bank | MD |
| 05/12 | SIEMENS HEALTHINEERS : JP Morgan gives a Buy rating | MD |
| 05/11 | Declaration of Voting Results by Danaher Corporation | CI |
| 05/11 | Declaration of Voting Results by Danaher Corporation | CI |
| 05/11 | SIEMENS HEALTHINEERS : Deutsche Bank reaffirms its Buy rating | MD |
| 05/11 | SIEMENS HEALTHINEERS : Gets a Buy rating from Barclays | MD |
| 05/11 | JPMorgan raises target for Siemens Healthineers - 'Overweight' | DP |
| 05/11 | SIEMENS HEALTHINEERS : Receives a Buy rating from JP Morgan | MD |
| 05/10 | Shockwave Medical Reportedly Picks Up Takeover Interest from Two Additional Suitors | CI |
| 05/10 | Siemens Healthineers : A somewhat weaker stance on Diagnostics | |
| 05/10 | Transcript : Danaher Corporation Presents at Bank of America Securities 2023 .. | CI |
| 05/10 | High Inflation, Rate Hikes Chatter Weigh on German Equities | MT |
| 05/10 | European Equities Close Lower in Wednesday Trading; ECB Reportedly Mulls September Rate.. | MT |
| 05/10 | Siemens Healthineers : Negative impacts from Corindus | |
| 05/10 | SIEMENS HEALTHINEERS : Gets a Buy rating from Bernstein | MD |
| 05/10 | Siemens Healthineers AG Reports Earnings Results for the Second Quarter and Six Months .. | CI |
| 05/10 | SIEMENS HEALTHINEERS : Barclays reaffirms its Buy rating | MD |
| 05/10 | German Shares Blink Red Amid Cautious Market Sentiment Before US Inflation Data | MT |
| 05/10 | SIEMENS HEALTHINEERS : UBS remains its Buy rating | MD |
| 05/10 | Diagnostics division puts Siemens Healthineers under pressure | DP |
| 05/10 | Diagnostics and robotics write-downs weigh on Siemens Healthineers | DP |
| 05/10 | Siemens Healthineers Shares Fall After Decline in 2Q Earnings, Revenue | DJ |
| 05/10 | SIEMENS HEALTHINEERS : Jefferies sticks Neutral | MD |
| 05/10 | SIEMENS HEALTHINEERS : JP Morgan reiterates its Buy rating | MD |
| 05/10 | Transcript : Siemens Healthineers AG, Q2 2023 Earnings Call, May 10, 2023 | CI |
| 05/10 | Siemens Healthineers 2Q Earnings, Revenue Hit by Waning Covid-19 Test Sales | DJ |
| 05/10 | Siemens Healthineers Posts Lower Fiscal Q2 Profit, Revenue | MT |
| 05/09 | Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on July 28, 2023 | CI |
| 05/08 | Insider Sell: Danaher | MT |
| 05/08 | Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Di.. | CI |
| 05/08 | EU draft Data Act puts trade secrets at risk, Siemens, SAP say | RE |
| 05/08 | Germany's SAP, Siemens Flag Trade Secret Risks in EU's Proposed Data Act | MT |
| 05/07 | Siemens, SAP say EU draft Data Act puts trade secrets at risk | RE |
| 05/05 | Insider Sell: Danaher | MT |
| 05/05 | Insider Sell: Danaher | MT |
| 05/05 | SIEMENS HEALTHINEERS : JP Morgan reiterates its Buy rating | MD |
| 05/03 | Insider Sell: Boston Scientific | MT |
| 05/02 | Insider Sell: Intuitive Surgical | MT |
| 05/02 | Insider Sell: Danaher | MT |
| 05/02 | UBS Adjusts Danaher Price Target to $277 From $306, Maintains Buy Rating | MT |
| 05/02 | Zimmer Biomet raises annual forecasts on knees and hips unit strength | RE |
| 05/01 | SVB Securities Starts Danaher at Outperform With $300 Price Target | MT |
| 04/28 | Intuitive Surgical Secures FDA Clearance for Da Vinci SP's Use in Simple Prostatectomy | MT |
| 04/28 | Intuitive Surgical's da Vinci SP System Gets FDA OK For Some Prostatectomies | DJ |
| 04/28 | Intuitive Surgical, Inc. Receives FDA Clearance of Da Vinci SP for Simple Prostatectomy | CI |
| 04/27 | UBS Raises Boston Scientific's Price Target to $60 From $57, Maintains Buy Rating | MT |
| 04/27 | Deutsche Bank Adjusts Danaher Price Target to $275 From $310, Maintains Buy Rating | MT |
| 04/27 | Deutsche Bank Adjusts Boston Scientific Price Target to $55 From $45, Maintains Hold Ra.. | MT |
| 04/27 | Canaccord Genuity Adjusts Price Target on Boston Scientific to $58 From $53, Maintains .. | MT |
| 04/27 | Barclays Adjusts Price Target on Boston Scientific to $56 From $53, Maintains Overweigh.. | MT |
| 04/27 | Morgan Stanley Adjusts Price Target on Boston Scientific to $58 From $56, Maintains Ove.. | MT |
| 04/27 | RBC Capital Adjusts Price Target on Boston Scientific to $56 From $53, Maintains Outper.. | MT |
| 04/27 | Needham Adjusts Price Target on Boston Scientific to $57 From $56, Maintains Buy Rating | MT |
| 04/26 | Nephron Research Cuts Danaher's Price Target to $255 From $270, Hold Rating Kept | MT |
| 04/26 | Morningstar Upgrades Danaher to Hold From Sell, Maintains Price Target at $242 | MT |
| 04/26 | JPMorgan Lowers Danaher's Price Target to $300 From $325, Maintains Overweight Rating | MT |
| 04/26 | Citigroup Adjusts Price Target on Danaher to $300 From $325, Maintains Buy Rating | MT |
| 04/26 | TD Cowen Adjusts Price Target on Danaher to $290 From $320, Maintains Outperform Rating | MT |
| 04/26 | Stifel Adjusts Price Target on Danaher to $250 From $270, Maintains Hold Rating | MT |
| 04/26 | Goldman Sachs Adjusts Price Target on Danaher to $260 From $300, Maintains Buy Rating | MT |
| 04/26 | Boston Scientific 1Q Earnings Climb After Acquisitions, Product Launches | DJ |
| 04/26 | Barclays Adjusts Price Target on Danaher to $260 From $270, Maintains Overweight Rating | MT |
| 04/26 | Credit Suisse Cuts Danaher's Price Target to $270 From $300 After In Line Q1 Results, L.. | MT |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
